Hepatitis B virus reactivation in kidney transplant patients with resolved hepatitis B virus infection: Risk factors and the safety and efficacy of preemptive therapy.
Takanori MeiHiroshi NoguchiYu HisadomeKeizo KakuTakehiro NishikiYasuhiro OkabeMasafumi NakamuraPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2020)
These results suggest that HBc Ab titer and age could be significant risk factors for HBV reactivation. Resolution of HBV infection did not appear to be associated with patient or graft survival, regardless of whether HBV reactivation occurred, when following our preemptive strategy.